Procurement and Pricing of New Vaccines for Developing Countries

Several vaccines that have come to market, including the rotavirus, pneumococcal conjugate, and human papillomavirus vaccines, have the potential to bring large public health benefits to developing countries. This eight-page policy brief explains how these vaccines and others are purchased for the public sector in developing countries, with a focus on the roles of the United Nations Children's Fund (UNICEF) and the Pan American Health Organization, as well as the GAVI Alliance, which is the major source of vaccine financing for the poorest countries and works closely with UNICEF. The brief describes the procurement process during which vaccine prices emerge and reviews data on vaccine prices in industrialized and developing countries.

Follow the VRL

Free access to journal articles for users in the developing world

Some resources in the VRL require a subscription to view the full text. The World Health Organization’s (WHO) Health InterNetwork Access to Research Initiative (HINARI) provides free or very low cost online access to the major journals in biomedical and related social sciences to local, not-for-profit institutions in developing countries.